Notably, our recent study has demonstrated that the synthetic peptides from HSP65 inhibit pro-inflammatory cytokine secretion by peripheral blood mononuclear cells from RA patients [9]. This evidence concerns the gene HSPD1 and rheumatoid arthritis.